Sugarbaker Paul H
Center for Gastrointestinal Malignancies, Program in Peritoneal Surface Oncology, MedStar Washington Hospital Center, Washington, DC, USA.
Ann Transl Med. 2017 Jun;5(11):231. doi: 10.21037/atm.2016.11.44.
Malignant pleural mesothelioma is a disease characterized by persistent and progressive disease within the hemithorax. However, after aggressive local-regional treatment using surgery, regional chemotherapy, radiation therapy, and systemic chemotherapy, metastases outside of the pleural space may become the chief obstacle to long-term survival. One possible direction of cancer dissemination is direct extension through the hemidiaphragm into the peritoneal space by the disease itself or as a result of diaphragm resection. In those patients who have isolated progression of disease within the peritoneal space, evaluation of their clinical condition using prognostic indicators is essential. Patients with a limited extent of disease and favorable radiologic findings by CT should be considered for cytoreductive surgery using peritonectomy procedures and perioperative combined intraperitoneal and systemic chemotherapy. Although few patients with pleural to peritoneal disease extension have been treated, some favorable long-term results suggest that selected patients should be thoroughly evaluated for disease control within the abdominal and pelvic space.
恶性胸膜间皮瘤是一种以半侧胸腔内疾病持续进展为特征的疾病。然而,在采用手术、区域化疗、放射治疗和全身化疗进行积极的局部区域治疗后,胸膜外转移可能成为长期生存的主要障碍。癌症播散的一个可能方向是疾病本身直接通过膈肌延伸至腹膜腔,或因膈肌切除而导致。对于那些腹膜腔内疾病孤立进展的患者,使用预后指标评估其临床状况至关重要。疾病范围有限且CT影像学表现良好的患者,应考虑采用腹膜切除术及围手术期腹腔内与全身联合化疗进行减瘤手术。尽管很少有胸膜疾病延伸至腹膜的患者接受过治疗,但一些良好的长期结果表明,应全面评估选定患者以控制腹盆腔内的疾病。